Astrana Health, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Shows how well the company's health networks performed, which affects investor confidence in operations.
John Vong replaces him; knowing leadership changes helps you track company stability and experience.
More shares available for employee bonuses dilutes ownership; important for understanding future stock value.
Leadership departures can signal problems, but this one was amicable and unrelated to disagreements.
Companies refresh presentations to show latest strategy; helps you see what management prioritizes.
Quarterly earnings show if the company is profitable and growing, which matters for investment decisions.
Financial results and management discussion reveal whether the business is performing well or struggling.
Stocky reads Astrana Health, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Astrana Health, Inc.'s most recent tracked filing was a 8-K on 13 Jul 2026: Astrana discloses accountable care organizations 2024 performance.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.